Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?-Reference-Cited by-同舟云学术

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?

Published:2019-10 Issue:5 Volume:71 Page:
ISSN:0393-2249
Container-title:Minerva Urologica e Nefrologica
language:
Short-container-title:Minerva Urol Nefrol

Author:

Gómez Rivas Juan,Carrion Diego M.,Alvarez-Maestro Mario,Cathelineau Xavier,Sanchez-Salas Rafael,Di Lorenzo Giuseppe,Di Maio Massimo,Paul Asit,Martinez-Piñeiro Luis,Sartor Oliver,Saad Fred,Debruyne Francis

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2019N05A0445

Reference67 articles.

1. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory

2. Prevalence of Osteoporosis During Long-Term Androgen Deprivation Therapy in Patients with Prostate Cancer

3. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

4. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer

5. Economic burden of cancer across the European Union: a population-based cost analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progression in the Mechanism of Bone Metastasis and Bone-Targeted Drugs in Prostate Cancer;annals of urologic oncology;2024-02-24

2. Optimización del manejo de los efectos adversos óseos derivados de la terapia de privación de andrógenos en el escenario del cáncer de próstata no resistente a la castración;Actas Urológicas Españolas;2023-03

3. Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study;Minerva Urology and Nephrology;2023-01

4. A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease;Asian Journal of Urology;2022-11

5. Do disease status and race affect the efficacy of zoledronic acid in patients with prostate cancer? A systematic review and meta-analysis of randomized control trials;PLOS ONE;2022-09-22